Go Pro

Hsbc Holdings PLC Boosts Stock Holdings in Addus HomeCare Corporation $ADUS

Addus HomeCare logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Hsbc Holdings PLC increased its Addus HomeCare stake by 73.3% in the second quarter, bringing its holdings to 24,463 shares valued at approximately $2.45 million. Institutional investors collectively own 95.35% of ADUS.
  • Addus HomeCare reported quarterly earnings of $1.73 per share, beating estimates by $0.03, while revenue rose 8% year over year to $377.41 million.
  • Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $128.86, compared with the stock’s opening price of $117.09.
  • MarketBeat previews top five stocks to own in October.

Hsbc Holdings PLC lifted its position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 73.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 24,463 shares of the company's stock after purchasing an additional 10,350 shares during the quarter. Hsbc Holdings PLC owned about 0.13% of Addus HomeCare worth $2,446,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in ADUS. Royal Bank of Canada grew its position in Addus HomeCare by 24.3% in the first quarter. Royal Bank of Canada now owns 6,899 shares of the company's stock worth $682,000 after acquiring an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Addus HomeCare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company's stock worth $1,026,000 after purchasing an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company's stock worth $5,111,000 after acquiring an additional 2,952 shares during the period. Jane Street Group LLC increased its holdings in Addus HomeCare by 387.6% during the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company's stock worth $1,092,000 after purchasing an additional 8,780 shares during the period. Finally, Intech Investment Management LLC raised its holdings in shares of Addus HomeCare by 44.7% in the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company's stock valued at $1,420,000 after acquiring an additional 4,439 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, insider Heather Dixon sold 288 shares of Addus HomeCare stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the sale, the insider owned 44,371 shares in the company, valued at $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of brokerages recently weighed in on ADUS. Barclays upped their price objective on Addus HomeCare from $92.00 to $96.00 and gave the stock an "underweight" rating in a research note on Wednesday, July 8th. Royal Bank Of Canada raised their price target on Addus HomeCare from $130.00 to $134.00 and gave the stock an "outperform" rating in a report on Wednesday, August 5th. Weiss Ratings upgraded Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, July 9th. Citizens Jmp reaffirmed a "market outperform" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research report on Monday, May 18th. Finally, Citigroup reiterated a "market outperform" rating on shares of Addus HomeCare in a research note on Friday, July 24th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Addus HomeCare currently has a consensus rating of "Moderate Buy" and an average price target of $128.86.

Get Our Latest Report on ADUS

Addus HomeCare Trading Down 1.2%

Shares of ADUS stock opened at $117.09 on Friday. The company's 50-day moving average price is $115.65 and its 200-day moving average price is $103.35. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. The stock has a market cap of $2.19 billion, a price-to-earnings ratio of 20.54, a PEG ratio of 1.59 and a beta of 0.86. Addus HomeCare Corporation has a twelve month low of $87.95 and a twelve month high of $124.43.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping analysts' consensus estimates of $1.70 by $0.03. The company had revenue of $377.41 million for the quarter, compared to the consensus estimate of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. Addus HomeCare's quarterly revenue was up 8.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.49 earnings per share. As a group, equities analysts predict that Addus HomeCare Corporation will post 6.3 earnings per share for the current year.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Further Reading

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS - Free Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines